Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. - Johanson,J.F.; Morton,D.; Geenen,J. (Am J Gastroenterol, 2008)